Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
Mertelsmann R, Drapkin RL, Gee TS, Kempin S, Passe S, Thaler HT, Arlin Z, Dowling M, Dufour P, McKenzie S, To L, Comacho E, Oettgen HF, Burchenal JH, Clarkson B.
Mertelsmann R, et al. Among authors: dowling m.
Cancer. 1981 Nov 15;48(10):2136-42. doi: 10.1002/1097-0142(19811115)48:10<2136::aid-cncr2820481003>3.0.co;2-1.
Cancer. 1981.
PMID: 6170414
Clinical Trial.